EWA
KNSA icon

EverSource Wealth Advisors’s Kiniksa Pharmaceuticals KNSA Stock Holding History

EverSource Wealth Advisors’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.3K Sell
427
-225
-35% -$11.7K ﹤0.01% 2212
2026
Q1 		$31.4K Buy
652
+106
+19% +$4.7K ﹤0.01% 2222
2025
Q4 		$22.5K Sell
546
-41
-7% -$1.65K ﹤0.01% 2308
2025
Q3 		$22.8K Sell
587
-324
-36% -$10.5K ﹤0.01% 2269
2025
Q2 		$25.2K Buy
911
+532
+140% +$13.5K ﹤0.01% 2118
2025
Q1 		$8.42K Buy
379
+366
+2,815% +$7.53K ﹤0.01% 2206
2024
Q4 		$257 Buy
+13
New +$297 ﹤0.01% 3373

Other funds holding KNSA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM

EverSource Wealth Advisors's KNSA Position: Q2 2026 in Review

EverSource Wealth Advisors reduced its Kiniksa Pharmaceuticals (KNSA) stake by 35% in Q2 2026, selling an estimated $11.7K and leaving 427 shares worth $27.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2212.

EverSource Wealth Advisors first reported a position in KNSA in Q4 2024 and has held it in 7 quarters since. The position peaked at $31.4K in Q1 2026. 266 funds tracked by Wall St. Rank hold KNSA as of Q2 2026.

  • EverSource Wealth Advisors held 427 shares of Kiniksa Pharmaceuticals worth $27.3K as of Q2 2026.
  • EverSource Wealth Advisors sold 225 Kiniksa Pharmaceuticals shares in Q2 2026, an estimated $11.7K.
  • Kiniksa Pharmaceuticals made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #2212 holding.
  • EverSource Wealth Advisors first reported a position in Kiniksa Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • EverSource Wealth Advisors's Kiniksa Pharmaceuticals position peaked at $31.4K in Q1 2026.
  • 266 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.